| Early immune-related adverse events and association with outcome in advanced non–small cell lung cancer patients treated with nivolumab: a prospective cohort study S Teraoka, D Fujimoto, T Morimoto, H Kawachi, M Ito, Y Sato, K Nagata, ... Journal of Thoracic Oncology 12 (12), 1798-1805, 2017 | 358 | 2017 |
| Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor: comparison between t790m mutation … A Hata, N Katakami, H Yoshioka, J Takeshita, K Tanaka, S Nanjo, S Fujita, ... Cancer 119 (24), 4325-4332, 2013 | 194 | 2013 |
| Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic R Tachikawa, K Tomii, H Ueda, K Nagata, S Nanjo, A Sakurai, K Otsuka, ... Respiration 83 (1), 20-27, 2012 | 157 | 2012 |
| Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease. A multicenter randomized crossover trial K Nagata, T Kikuchi, T Horie, A Shiraki, T Kitajima, T Kadowaki, F Tokioka, ... Annals of the American Thoracic Society 15 (4), 432-439, 2018 | 112 | 2018 |
| Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients D Fujimoto, K Uehara, Y Sato, I Sakanoue, M Ito, S Teraoka, K Nagata, ... Scientific reports 7 (1), 11373, 2017 | 86 | 2017 |
| Efficacy of high-flow nasal cannula therapy in acute hypoxemic respiratory failure: decreased use of mechanical ventilation K Nagata, T Morimoto, D Fujimoto, T Otoshi, A Nakagawa, K Otsuka, ... Respiratory care 60 (10), 1390-1396, 2015 | 86 | 2015 |
| Enteral nutrition is a risk factor for airway complications in subjects undergoing noninvasive ventilation for acute respiratory failure M Kogo, K Nagata, T Morimoto, J Ito, Y Sato, S Teraoka, D Fujimoto, ... Respiratory Care 62 (4), 459-467, 2017 | 76 | 2017 |
| A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia D Fujimoto, T Morimoto, J Ito, Y Sato, M Ito, S Teraoka, K Otsuka, ... Lung Cancer 111, 1-5, 2017 | 75 | 2017 |
| Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease K Nagata, K Tomii, K Otsuka, R Tachikawa, K Otsuka, J Takeshita, ... Respirology 17 (3), 506-512, 2012 | 63 | 2012 |
| Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis D Fujimoto, H Ueda, R Shimizu, R Kato, T Otoshi, T Kawamura, K Tamai, ... Clinical & experimental metastasis 31, 543-551, 2014 | 59 | 2014 |
| Home high-flow nasal cannula oxygen therapy for stable hypercapnic COPD: a randomized clinical trial K Nagata, T Horie, N Chohnabayashi, T Jinta, R Tsugitomi, A Shiraki, ... American Journal of Respiratory and Critical Care Medicine 206 (11), 1326-1335, 2022 | 58 | 2022 |
| Predictive performance of four programmed cell death ligand 1 assay systems on nivolumab response in previously treated patients with non–small cell lung cancer D Fujimoto, Y Sato, K Uehara, K Ishida, J Fukuoka, T Morimoto, ... Journal of Thoracic Oncology 13 (3), 377-386, 2018 | 58 | 2018 |
| Characteristics and prognostic impact of pneumonitis during systemic anti-cancer therapy in patients with advanced non-small-cell lung cancer D Fujimoto, R Kato, T Morimoto, R Shimizu, Y Sato, M Kogo, J Ito, ... PLoS One 11 (12), e0168465, 2016 | 58 | 2016 |
| The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial … R Shimizu, D Fujimoto, R Kato, T Otoshi, T Kawamura, K Tamai, ... Cancer chemotherapy and pharmacology 74, 1159-1166, 2014 | 57 | 2014 |
| Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation K Tanaka, A Hata, R Kaji, S Fujita, T Otoshi, D Fujimoto, T Kawamura, ... Journal of Thoracic Oncology 8 (7), 892-898, 2013 | 55 | 2013 |
| A Case of isolated IgG4-related interstitial pneumonia K Tanaka, K Nagata, K Tomii, Y Imai Chest 142 (1), 228-230, 2012 | 46 | 2012 |
| Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital T Matsumoto, K Tomii, R Tachikawa, K Otsuka, K Nagata, K Otsuka, ... BMC pulmonary medicine 15, 1-9, 2015 | 40 | 2015 |
| Detection of herpes viruses by multiplex and real-time polymerase chain reaction in bronchoalveolar lavage fluid of patients with acute lung injury or acute respiratory … R Tachikawa, K Tomii, R Seo, K Nagata, K Otsuka, A Nakagawa, ... Respiration 87 (4), 279-286, 2014 | 38 | 2014 |
| Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity Y Sato, D Fujimoto, T Morimoto, K Uehara, K Nagata, I Sakanoue, ... Respirology 22 (8), 1615-1621, 2017 | 37 | 2017 |
| Clinical characteristics and prognosis of patients with advanced non–small-cell lung cancer who are ineligible for clinical trials H Kawachi, D Fujimoto, T Morimoto, M Ito, S Teraoka, Y Sato, K Nagata, ... Clinical Lung Cancer 19 (5), e721-e734, 2018 | 35 | 2018 |
